Librería:
Kennys Bookstore, Olney, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Vendedor de AbeBooks desde 9 de octubre de 2009
N° de ref. del artículo V9789811676055
This informative book discusses the latest research on the risk factors and therapeutics in dementia. WHO calls dementia a public health priority. Dementia manifests as a group of symptoms associated with decline in memory or other thinking skills and is severe enough to reduce a person’s ability to perform everyday activities. It occurs frequently among elderly people, but it is not necessarily part of the normal aging process. The book has been divided into two broad sections. The first section reviews the risk factors involved in developing dementia, including various medical conditions, lifestyle choices, as well as genetics. The latter section describes various therapeutic interventions in dementia. Although there is no known cure for dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. This book highlights the global effort to find better ways to halt the progression of dementia and develop novel therapeutic strategies.
The book would be an interesting read for advanced graduate students and researchers working in the field of neuroscience, genetics, and medicine. It will generate good interest to neurologists, psychiatrists, geriatricians, cardiologists, internal medicine practitioners, epidemiologist, and public health workers.
Acerca del autor:
Ghulam Md Ashraf is currently working as an Associate Professor at King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. He has received his PhD in Biochemistry from Aligarh Muslim University, India in 2010. Dr. Ashraf has to his credit 273 publications ranging from peer-reviewed journal articles, books, and book chapters published with scholarly publishers (total citations: 4618, h-index: 33, i10-index: 128). He has been involved in 19 research projects funded by various agencies of Saudi Arabia, and is associated with renowned professional societies like Royal Society of Medicine (Fellow), Royal Society of Biology (Member) and American Society for Biochemistry and Molecular Biology (Member). Dr. Ashraf’s current research work focuses on investigating the role of anti-diabetic drugs in pyschotic and dementia conditions. Dr. Ashraf is also involved in editorial capacity with many reputed journals like PLOS one, Scientific Reports, Current Neuropharmacology, Frontiers in Bioscience-Landmark, Neural Regeneration Research, Current Proteins and Peptides, Journal of Proteomics, to mention a few.
Md. Sahab Uddin is a Registered Pharmacist and a Research Scholar in the Department of Pharmacy at Southeast University, Dhaka, Bangladesh. Md. Uddin’s research interest is how neuronal operation can be restored to abate Alzheimer’s dementia. He has published copious articles in peer-reviewed international scientific journals. Md. Uddin has been enlisted in the Stanford University Lists of World's Top 2% Influencing Researchers based on the citation impact from Scopus of the single calendar year 2019. He has also authored and edited several books related to neuropharmacology and neurodegenerative disorders. Md. Uddin also serves as a guest editor, editorial, and reviewer board member of numerous scholarly journals. He is an active ad-hoc reviewer for more than 50 journals and reviewed more than 200 papers. Md. Uddin is a member of many national and international professional bodies. Moreover, he is the Founder and Executive Director of the Pharmakon Neuroscience Research Network, an open innovation hub bringing together neuroscientists to advance brain health. He received his BPharm in 2014, securing a first position from the Department of Pharmacy, Southeast University, Bangladesh.
Título: Current Thoughts On Dementia : From Risk
Editorial: Springer
Año de publicación: 2022
Encuadernación: Encuadernación de tapa dura
Condición: New
Librería: Brook Bookstore, Milano, MI, Italia
Condición: new. Nº de ref. del artículo: W9QKXKEDMT
Cantidad disponible: 5 disponibles
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
Condición: new. Nº de ref. del artículo: W9QKXKEDMT
Cantidad disponible: 5 disponibles
Librería: moluna, Greven, Alemania
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Describes the different risk factors with age, conditions like diabetes, hypertension, Down SyndromeDiscusses therapeutics like calcium channel blockers, Choline-containing phospholipids, Cholinesterase inhibitorsSheds light on off beat the. Nº de ref. del artículo: 512679222
Cantidad disponible: Más de 20 disponibles
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Hardcover. Condición: new. Hardcover. This informative book discusses the latest research on the risk factors and therapeutics in dementia. WHO calls dementia a public health priority. Dementia manifests as a group of symptoms associated with decline in memory or other thinking skills and is severe enough to reduce a person's ability to perform everyday activities. It occurs frequently among elderly people, but it is not necessarily part of the normal aging process. The book has been divided into two broad sections. The first section reviews the risk factors involved in developing dementia, including various medical conditions, lifestyle choices, as well as genetics. The latter section describes various therapeutic interventions in dementia. Although there is no known cure for dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. This book highlights the global effort to find better ways to halt the progression of dementia and develop novel therapeutic strategies. The book would be an interesting read for advanced graduate students and researchers working in the field of neuroscience, genetics, and medicine. It will generate good interest to neurologists, psychiatrists, geriatricians, cardiologists, internal medicine practitioners, epidemiologist, and public health workers. This informative book discusses the latest research on the risk factors and therapeutics in dementia. Although there is no known cure for dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Nº de ref. del artículo: 9789811676055
Cantidad disponible: 1 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 44632731-n
Cantidad disponible: Más de 20 disponibles
Librería: Revaluation Books, Exeter, Reino Unido
Hardcover. Condición: Brand New. 639 pages. 9.25x6.10x1.38 inches. In Stock. This item is printed on demand. Nº de ref. del artículo: __9811676054
Cantidad disponible: 2 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: New. Nº de ref. del artículo: 44632731-n
Cantidad disponible: Más de 20 disponibles
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This informative book discusses the latest research on the risk factors and therapeutics in dementia. WHO calls dementia a public health priority. Dementia manifests as a group of symptoms associated with decline in memory or other thinking skills and is severe enough to reduce a person's ability to perform everyday activities. It occurs frequently among elderly people, but it is not necessarily part of the normal aging process. The book has been divided into two broad sections. The first section reviews the risk factors involved in developing dementia, including various medical conditions, lifestyle choices, as well as genetics. The latter section describes various therapeutic interventions in dementia. Although there is no known cure for dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. This book highlights the global effort to find better ways to halt the progression of dementia and develop novel therapeutic strategies.The book would be an interesting read for advanced graduate students and researchers working in the field of neuroscience, genetics, and medicine. It will generate good interest to neurologists, psychiatrists, geriatricians, cardiologists, internal medicine practitioners, epidemiologist, and public health workers.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 640 pp. Englisch. Nº de ref. del artículo: 9789811676055
Cantidad disponible: 1 disponibles
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This informative book discusses the latest research on the risk factors and therapeutics in dementia. WHO calls dementia a public health priority. Dementia manifests as a group of symptoms associated with decline in memory or other thinking skills and is severe enough to reduce a person's ability to perform everyday activities. It occurs frequently among elderly people, but it is not necessarily part of the normal aging process. The book has been divided into two broad sections. The first section reviews the risk factors involved in developing dementia, including various medical conditions, lifestyle choices, as well as genetics. The latter section describes various therapeutic interventions in dementia. Although there is no knowncurefor dementia, this book underlines the current treatment strategies that could momentarily reduce the symptoms and improve the quality of life of the patients. This book highlights the global effort to find better ways to halt the progression of dementia and develop novel therapeutic strategies. The book would be an interesting read for advanced graduate students and researchers working in the field of neuroscience, genetics, and medicine. It will generate good interest toneurologists, psychiatrists, geriatricians, cardiologists, internal medicine practitioners, epidemiologist, and public health workers. 640 pp. Englisch. Nº de ref. del artículo: 9789811676055
Cantidad disponible: 2 disponibles
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Condición: New. In. Nº de ref. del artículo: ria9789811676055_new
Cantidad disponible: Más de 20 disponibles